2023 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2023-12-08
±³À°ÀÏÀÚ : 2023-12-08
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽÇ
±³À°ÁÖÁ¦ : 2023 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ
´ã´çÀÚ : ±èÁø¿Á
¿¬¶ôó : 070-4888-5737
À̸ÞÀÏ : sericonf@hanmail.net
±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í " »çÀüµî·Ï/ÇöÀåµî·Ï
Àü¹®ÀÇ 30,000¿ø /50,000¿ø
Àü°øÀÇ, ±ºÀü¹®ÀÇ 20,000¿ø / 30,000¿ø
Æò»ýȸ¿ø ¹«·á /10,000¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 09:30~09:55 Psychosomatic and vasomotor symptom changes during transition to menopause À̾ƶó(°æÈñÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 09:55~10:20 Management of premenstrual syndrome and premenstrual dysphoric disorder Á¤»çÀÓ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 10:20~10:45 Update on postpartum depression: FDA Approves first oral treatment for postpartum depression È«Á¤¿Ï(Àͻ꺴¿ø)
Åä·Ð 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 10:45~10:55 Q&A ()
ÈÞ½Ä 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 10:55~11:05 Coffee Break ()
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 11:05~11:30 Depression preceding Parkinson¡¯s disease: Risk factor or early symptoms? ½Åö¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 11:30~11:55 Depression in rheumatic disease and the role of disease-related factors °¿ø¼·(°æÈñÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 11:55~12:20 Depression with glycemic control in diabetic patients ¼Û¹Î±Ô(¼º¸ð°ø°¨Á¤½Å°Ç°ÀÇÇаú)
Åä·Ð 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 12:20~12:30 Q&A ()
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 12:30~13:30 Olanzapine Efficacy for Anxiety, Agitation, and Sleep Disturbances in Mood Disorders ÀüÈ«ÁØ(°Ç±¹ÀÇ´ë)
ÈÞ½Ä 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 13:30~13:40 Coffee Break ()
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 13:40~14:05 Agitation from a general medical condition: Medical evaluation of agitated patient ÀÌ°æȯ(ºÀ»ý±â³äº´¿ø)
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 14:05~14:30 Agitation and aggression in dementia patients ¾öÀ¯Çö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 14:30~14:55 Treatment of agitation following traumatic brain injury ¾çÇöÁÖ(Á¦ÁÖÀÇ´ë)
Åä·Ð 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 14:55~15:05 Q&A ()
ÈÞ½Ä 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 15:05~15:15 Coffee Break ()
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 15:15~15:40 Panic Disorder Reconsidered: Delineating Its Status as an Autonomous Entity Versus a Non-Specific Stress Reaction Through the Lens of Comorbidity Studies ÀüÈ«ÁØ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 15:40~16:05 Digital Health Service for Cancer Survivors: Personalized Information and Coaching for Healthy Living ±è¼±¹Ì(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 16:05~16:30 Recent updates in delirium research ¿ÀÁÖ¿µ(¿¬¼¼ÀÇ´ë)
Åä·Ð 12¿ù 08ÀÏ ÄÁº¥¼ÇȦ 16:30~16:40 Q&A ()
±³À°½Ã°£ 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 09:55~10:20 ½ÅüÁõ»óÀå¾ÖÀÇ Æò°¡ ¹× °¨º°Áø´Ü ±èÈñÁø(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 10:20~10:45 ½ÅüÁõ»óÀå¾ÖÀÇ ¾à¹°Ä¡·á ¹× Á¤½ÅÄ¡·á Àӿ쿵(°Ç¾çÀÇ´ë)
Åä·Ð 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 10:45~10:55 Q&A ()
ÈÞ½Ä 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 10:55~11:05 Coffee break ()
±³À°½Ã°£ 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 11:05~11:30 ÀüȯÀå¾ÖÀÇ Æò°¡ ¹× °¨º°Áø´Ü À±¼¿µ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 11:30~11:55 ÀüȯÀå¾ÖÀÇ ¾à¹°Ä¡·á¿Í Á¤½ÅÄ¡·á ÃÖÀç¿ø(À»ÁöÀÇ´ë)
Åä·Ð 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 11:55~12:05 Q&A ()
±³À°½Ã°£ 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 13:40~14:05 ¼ÒȱâÁúȯ Áö¼öÇõ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 14:05~14:30 ½ÅÀåÁúȯ ±è°æ¹Î(°æºÏÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 14:30~14:55 ·ù¸¶Æ¼½ºÁúȯ ±è¿øÇü(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 14:55~15:20 ¾Ï(Á¤½ÅÁ¾¾çÇÐ) ¹ÚÇýÀ±(¼¿ïÀÇ´ë)
Åä·Ð 12¿ù 08ÀÏ ´ëȸÀÇ½Ç 15:20~15:30 Q&A ()